PGL-135
PGL-135 is a blood-brain barrier-permeable Huntingtin aggregation inhibitor. PGL-135 is applicable to research related to Huntington's disease.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 26278-83-1
- 화학식: C9H10N2OS
- 분자량:194.25
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
PGL-135 (25-50 μM) inhibits the aggregation of HDQ51 in 293 Tet-Off cells expressing HDQ51, with an IC50 of 40 μM; it reduces inclusion body formation by 30% at a concentration of 25 μM and by 50% at 50 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:hemizygote R6/2 (female, 10-11 weeks old, CBA × C57BL/6 F1 background); wild-type littermates (female, 10-11 weeks old, CBA × C57BL/6 F1 background)[1]
-
Dosage:30 mg/kg
-
Administration:i.p.; single dose
-
Result:Was detectable in micromolar concentrations in brain and serum during the first 30 minutes post-injection.
Was virtually undetectable by 40 minutes post-injection.
Was not reliably detectable in liver at any time point.
Chemical Information
-
CAS No. 26278-83-1
-
분자량 194.25
-
화학식 C9H10N2OS
-
SMILES
OC1=CC(=C2N=C(SC2=C1C)N)C
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)